{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:53:05Z","timestamp":1790704385178,"version":"4.1.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016990","name":"Beneficentia Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jinorgbio.2021.111355","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T11:39:48Z","timestamp":1611142788000},"page":"111355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes"],"prefix":"10.1016","volume":"217","author":[{"given":"Federica","family":"Guarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pratesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Gabbiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarita","family":"Biver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2021.111355_bb0005","first-page":"1","article-title":"Recent advances in subcellular targeted Cancer therapy based on functional materials","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: past, present and future","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02307573","article-title":"Cisplatin: synthesis, antitumour activity and mechanism of action","volume":"7","author":"Reedijk","year":"1985","journal-title":"Pharm. Weekbl. Sci. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0025","doi-asserted-by":"crossref","first-page":"110874","DOI":"10.1016\/j.jinorgbio.2019.110874","article-title":"DNA interaction of a fluorescent, cytotoxic pyridinimino platinum(II) complex","volume":"202","author":"Bondi","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2019.213067","article-title":"Multifunctional, heterometallic ruthenium-platinum complexes with medicinal applications","author":"Jain","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0035","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1002\/anie.201900934","article-title":"Subcellular duplex DNA and G-Quadruplex interaction profiling of a hexagonal PtII Metallacycle","volume":"58","author":"Domarco","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/molecules24030404","article-title":"Selectivity of Terpyridine platinum anticancer drugs for G-quadruplex DNA","volume":"24","author":"Morel","year":"2019","journal-title":"Molecules."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0045","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1039\/b813568a","article-title":"Targeting proteins with metal complexes","author":"Meggers","year":"2009","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0050","doi-asserted-by":"crossref","first-page":"54897","DOI":"10.18632\/oncotarget.10703","article-title":"PIM kinases as therapeutic targets against advanced melanoma","volume":"7","author":"Shannan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.09.010","article-title":"Power of mitochondrial drug delivery systems to produce innovative nanomedicines","author":"Yamada","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2017.10.022","article-title":"Organelle-targeting metal complexes: from molecular design to bio-applications","volume":"378","author":"Qiu","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0065","series-title":"Metal N-Heterocyclic Carbene Complexes in Medicinal Chemistry","author":"Ott","year":"2020"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0070","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1021\/ja9527075","article-title":"Electronic structure of stable Carbenes, Silylenes, and Germylenes","volume":"118","author":"Boehme","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0075","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1002\/anie.201602702","article-title":"N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery","volume":"55","author":"Niu","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0080","doi-asserted-by":"crossref","first-page":"11976","DOI":"10.1002\/anie.201306682","article-title":"Metal\/N-heterocyclic carbene complexes: opportunities for the development of anticancer metallodrugs","volume":"52","author":"Cisnetti","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0085","series-title":"Quantifying and Understanding the Electronic Properties of N-Heterocyclic Carbenes","author":"Nelson","year":"2013"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0090","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.trechm.2020.06.001","article-title":"Synthetic routes to late transition metal\u2013NHC complexes","volume":"2","author":"Scattolin","year":"2020","journal-title":"Trends Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0095","doi-asserted-by":"crossref","first-page":"213411","DOI":"10.1016\/j.ccr.2020.213411","article-title":"Recent progress on NHC-stabilized early transition metal (group 3\u20137) complexes: synthesis and applications","volume":"422","author":"Romain","year":"2020","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF03214805","article-title":"China\u2019s ancient gold drugs","volume":"34","author":"Huaizhi","year":"2001","journal-title":"Gold Bull."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF03214618","article-title":"Gold in medicine","volume":"15","author":"Higby","year":"1982","journal-title":"Gold Bull."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03214639","article-title":"Gold compounds for rheumatoid arthritis","volume":"19","author":"Sutton","year":"1986","journal-title":"Gold Bull."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0049-0172(85)90037-X","article-title":"The history of gold therapy in rheumatoid disease","volume":"14","author":"Kean","year":"1985","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/0929867324666170330091438","article-title":"Gold - old drug with new potentials","volume":"25","author":"Faa","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0125","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/molecules23061410","article-title":"Gold-based medicine: a paradigm shift in anti-Cancer therapy?","volume":"23","author":"Yeo","year":"2018","journal-title":"Molecules."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0130","series-title":"Metal-Based Anticancer Agents","year":"2019"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0135","series-title":"Argyria;the Pharmacology of Silver","author":"Hill","year":"1939"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0140","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1021\/acs.jmedchem.8b01439","article-title":"Medical uses of silver: history, myths, and scientific evidence","volume":"62","author":"Medici","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0145","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.biotechadv.2018.05.004","article-title":"Silver bullets: a new lustre on an old antimicrobial agent","volume":"36","author":"M\u00f6hler","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2004.11.014","article-title":"Bacterial resistance to silver in wound care","volume":"60","author":"Percival","year":"2005","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ccr.2016.05.015","article-title":"Silver coordination compounds: a new horizon in medicine","volume":"327\u2013328","author":"Medici","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejmech.2018.07.057","article-title":"Recent advances in the medical use of silver complex","volume":"157","author":"Liang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0165","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0170","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.1039\/C7DT01955F","article-title":"A perspective-can copper complexes be developed as a novel class of therapeutics?","volume":"46","author":"Wehbe","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0175","doi-asserted-by":"crossref","first-page":"21041","DOI":"10.1039\/C5DT02934A","article-title":"Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms","volume":"44","author":"Pellei","year":"2015","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0180","doi-asserted-by":"crossref","first-page":"111134","DOI":"10.1016\/j.jinorgbio.2020.111134","article-title":"Anticancer potency of copper(II) complexes of thiosemicarbazones","volume":"210","author":"Singh","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0185","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/092986709787846532","article-title":"Copper compounds in anticancer strategies","volume":"16","author":"Tardito","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/0929867324666170511152441","article-title":"Drug delivery systems for anti-Cancer active complexes of some coinage metals","volume":"25","author":"Zhang","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0195","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and Cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0205","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s13238-014-0089-1","article-title":"Mitochondria-mediated apoptosis in mammals","volume":"5","author":"Xiong","year":"2014","journal-title":"Prot. Cell."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.mito.2006.07.006","article-title":"The role of the mitochondrial permeability transition in cell death","volume":"6","author":"Armstrong","year":"2006","journal-title":"Mitochondrion."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0220","doi-asserted-by":"crossref","first-page":"14314","DOI":"10.1074\/jbc.M513297200","article-title":"Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells","volume":"281","author":"Machida","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0225","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0230","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ccr.2007.04.006","article-title":"Targeting the mitochondrial cell death pathway with gold compounds","volume":"251","author":"Barnard","year":"2007","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0235","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.18632\/oncotarget.13475","article-title":"The role of p53 in cancer drug resistance and targeted chemotherapy","volume":"8","author":"Hientz","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"P53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0245","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/carcin\/bgn093","article-title":"Bioenergetic differences selectively sensitize tumorigenic liver progenitor cells to a new gold(I) compound","volume":"29","author":"Jellicoe","year":"2008","journal-title":"Carcinogenesis."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0250","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-409X(01)00125-9","article-title":"Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells","volume":"49","author":"Modica-Napolitano","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0255","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2174\/0929867325666180307112029","article-title":"Mitochondria-targeting anticancer metal complexes","volume":"26","author":"Erxleben","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0260","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/acs.biochem.9b00857","article-title":"Mitochondrion-targeting peptides and peptidomimetics: recent progress and design principles","volume":"59","author":"Kim","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0265","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1002\/anie.201806002","article-title":"Highly selective mitochondrial targeting by a ruthenium(II) peptide conjugate: imaging and Photoinduced damage of mitochondrial DNA","volume":"57","author":"Burke","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0270","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0006-2952(93)90144-L","article-title":"Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes","volume":"45","author":"Anderson","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0275","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0006-291X(84)91453-0","article-title":"Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondria","volume":"118","author":"Modica-Napolitano","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0280","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1021\/jm500174v","article-title":"Antiproliferative and uncoupling effects of delocalized, lipophilic, cationic gallic acid derivatives on cancer cell lines. Validation in vivo in singenic mice","volume":"57","author":"Jara","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0285","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.1021\/acs.jmedchem.8b01595","article-title":"Targeting the Thioredoxin system as a strategy for Cancer therapy","volume":"62","author":"Bian","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0290","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ncomms1382","article-title":"Crystal structure of the human thioredoxin reductase\u2013thioredoxin complex","volume":"2","author":"Fritz-Wolf","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0295","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2005.04.028","article-title":"Thioredoxin reductase as a novel molecular target for cancer therapy","volume":"236","author":"Nguyen","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.freeradbiomed.2018.03.043","article-title":"Significance of the mitochondrial thioredoxin reductase in cancer cells: an update on role, targets and inhibitors","volume":"127","author":"Scalcon","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0305","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.semcancer.2006.09.004","article-title":"On the potential of thioredoxin reductase inhibitors for cancer therapy","volume":"16","author":"Urig","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0310","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1039\/C0MD00181C","article-title":"Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(iii) compounds studied with combined mass spectrometry and biochemical assays","volume":"2","author":"Gabbiani","year":"2011","journal-title":"Medchemcomm."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0315","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.ccr.2009.02.026","article-title":"Thioredoxin reductase: a target for gold compounds acting as potential anticancer drugs","volume":"253","author":"Bindoli","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0320","first-page":"10381038","article-title":"Dinuclear gold(i) complexes of bridging bidentate carbene ligands: synthesis, structure and spectroscopic characterisation","volume":"40","author":"Barnard","year":"2004","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0325","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jinorgbio.2004.05.011","article-title":"Mitochondrial permeability transition induced by dinuclear gold(I)\u2013carbene complexes: potential new antimitochondrial antitumour agents","volume":"98","author":"Barnard","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0330","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1039\/b602560a","article-title":"Cationic, linear Au(I) N-heterocyclic carbene complexes: synthesis, structure and anti-mitochondrial activity","volume":"30","author":"Baker","year":"2006","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0335","doi-asserted-by":"crossref","first-page":"12570","DOI":"10.1021\/ja804027j","article-title":"Mitochondria-targeted chemotherapeutics: the rational design of Gold(I) N-Heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols","volume":"130","author":"Hickey","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0340","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1039\/C4DT00429A","article-title":"\u2018Auto-click\u2019 functionalization for diversified copper(i) and gold(i) NHCs","volume":"43","author":"Ibrahim","year":"2014","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0345","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1039\/C9CC05635A","article-title":"Expanding the biological utility of bis-NHC gold(i) complexes through post synthetic carbamate conjugation","volume":"55","author":"Sen","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0350","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1021\/acschembio.5b00268","article-title":"Mitochondrial targeting of doxorubicin eliminates nuclear effects associated with Cardiotoxicity","volume":"10","author":"Jean","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0355","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/cmdc.201200055","article-title":"Anticancer activity of silver-N-heterocyclic Carbene complexes: Caspase-independent induction of apoptosis via mitochondrial apoptosis-inducing factor (AIF)","volume":"7","author":"Eloy","year":"2012","journal-title":"ChemMedChem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0360","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1039\/C4MT00046C","article-title":"Antitumor properties and mechanisms of mitochondria-targeted Ag(i) and au(i) complexes containing N-heterocyclic carbenes derived from cyclophanes","volume":"6","author":"Li","year":"2014","journal-title":"Metallomics."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0365","doi-asserted-by":"crossref","first-page":"103552","DOI":"10.1016\/j.bioorg.2019.103552","article-title":"Chemistry, structure, and biological roles of au-NHC complexes as TrxR inhibitors","volume":"95","author":"Karaaslan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0370","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1039\/C7MT00327G","article-title":"Modulation of thiol-dependent redox system by metal ions: Via thioredoxin and glutaredoxin systems","volume":"10","author":"Ouyang","year":"2018","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0375","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1021\/jm201220n","article-title":"Comparative in vitro evaluation of N-heterocyclic Carbene gold(I) complexes of the Benzimidazolylidene type","volume":"54","author":"Rubbiani","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0380","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jinorgbio.2014.01.009","article-title":"Insights on the mechanism of thioredoxin reductase inhibition by gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): an ESI-MS investigation","volume":"136","author":"Pratesi","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0385","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1039\/c0cc01465f","article-title":"Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis","volume":"46","author":"Pratesi","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0390","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1039\/C4MT00075G","article-title":"Detailed analysis of pro-apoptotic signaling and metabolic adaptation triggered by a N-heterocyclic carbene-gold(I) complex","volume":"6","author":"Holenya","year":"2014","journal-title":"Metallomics."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0395","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1039\/c3md00076a","article-title":"TrxR inhibition and antiproliferative activities of structurally diverse gold N-heterocyclic carbene complexes","volume":"4","author":"Rubbiani","year":"2013","journal-title":"Medchemcomm."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0400","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1021\/om300444c","article-title":"Syntheses, characterizations, and a preliminary comparative cytotoxicity study of gold(I) and gold(III) complexes bearing benzimidazole- and pyrazole-derived N-heterocyclic carbenes","volume":"31","author":"Sivaram","year":"2012","journal-title":"Organometallics."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0405","article-title":"Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates","volume":"7063","author":"Lemke","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0410","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.1021\/jm201156x","article-title":"NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents","volume":"54","author":"Liu","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0415","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/jm3000196","article-title":"Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5- diarylimidazol-2-ylidene]gold(I\/III) complexes","volume":"55","author":"Liu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0420","first-page":"5316","article-title":"In vitro biological activities of gold(I) and gold(III) Bis(N-heterocyclic Carbene) complexes","volume":"2","author":"Al-Majid","year":"2017","journal-title":"Chem. Sel."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0425","doi-asserted-by":"crossref","first-page":"17130","DOI":"10.1002\/anie.202008046","article-title":"124I radiolabeling of a AuIII-NHC complex for in vivo biodistribution studies","volume":"59","author":"Guarra","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0430","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/ic401731a","article-title":"Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents","volume":"53","author":"Messori","year":"2014","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0435","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cmdc.201700316","article-title":"Anticancer gold N-heterocyclic Carbene complexes: a comparative in vitro and ex vivo study","volume":"12","author":"Estrada-Ortiz","year":"2017","journal-title":"ChemMedChem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0440","doi-asserted-by":"crossref","first-page":"28042","DOI":"10.18632\/oncotarget.25556","article-title":"Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: a comparative proteomic study","volume":"9","author":"Magherini","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0445","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1039\/c3mt20260g","article-title":"Fluorescent silver(i) and gold(i)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights","volume":"5","author":"Citta","year":"2013","journal-title":"Metallomics."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0450","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/cmdc.201800672","article-title":"A fluorescent silver(I) carbene complex with anticancer properties: synthesis, characterization, and biological studies","volume":"14","author":"Fabbrini","year":"2019","journal-title":"ChemMedChem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0455","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1002\/anie.201400142","article-title":"A binuclear gold(I) complex with mixed bridging Diphosphine and Bis(N-heterocyclic Carbene) ligands shows favorable Thiol reactivity and inhibits tumor growth and angiogenesis in vivo","volume":"53","author":"Zou","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0460","doi-asserted-by":"crossref","first-page":"14237","DOI":"10.1021\/acs.inorgchem.7b02345","article-title":"Characterization of hydrophilic gold(I) N-heterocyclic Carbene (NHC) complexes as potent TrxR inhibitors using biochemical and mass spectrometric approaches","volume":"56","author":"Karaca","year":"2017","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0465","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1039\/c8mt00306h","article-title":"A gold(I) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugs","volume":"11","author":"Schmidt","year":"2019","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0470","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.5618","article-title":"Antiproliferative Activity of Gold(I) N-Heterocyclic Carbene and Triphenylphosphine Complexes with Ibuprofen Derivatives as Effective Enzyme Inhibitors","volume":"34","author":"Tabrizi","year":"2020","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0475","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1039\/C5CC09718E","article-title":"Versatile synthesis of cationic N-heterocyclic carbene-gold(I) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents","volume":"52","author":"Fern\u00e1ndez-Gallardo","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0480","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1039\/C5SC03519H","article-title":"Targeting antioxidant pathways with ferrocenylated N-heterocyclic carbene supported gold(I) complexes in A549 lung cancer cells","volume":"7","author":"Arambula","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0485","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1002\/anie.201209787","article-title":"Gold(III) complexes containing N-heterocyclic carbene ligands: Thiol \u201cswitch-on\u201d fluorescent probes and anti-cancer agents","volume":"52","author":"Zou","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0490","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1021\/ic3013188","article-title":"Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes","volume":"51","author":"Pellei","year":"2012","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0495","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jinorgbio.2013.09.011","article-title":"Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes","volume":"129","author":"Gandin","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0500","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/0929867324666170920125943","article-title":"Ag+ complexes as potential therapeutic agents in medicine and pharmacy","volume":"26","author":"Hecel","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0505","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/molecules22081263","article-title":"Recent developments in the medicinal applications of silver-NHC complexes and Imidazolium salts","volume":"22","author":"Johnson","year":"2017","journal-title":"Molecules."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0510","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/jm800101w","article-title":"Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study","volume":"51","author":"Krishnamurthy","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0515","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/cmdc.201400056","article-title":"Cytotoxic gold(I) N-heterocyclic carbene complexes with phosphane ligands as potent enzyme inhibitors","volume":"9","author":"Rubbiani","year":"2014","journal-title":"ChemMedChem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0520","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/jm2000135","article-title":"Metal-based inhibition of poly(ADP-ribose) polymerase-the guardian angel of DNA","volume":"54","author":"Mendes","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0525","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1021\/acs.jmedchem.6b00055","article-title":"An update on poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors: opportunities and challenges in cancer therapy","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0530","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","article-title":"Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation","volume":"33","author":"Kaufman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0535","doi-asserted-by":"crossref","first-page":"105594","DOI":"10.1016\/j.ejps.2020.105594","article-title":"Multiple topoisomerase I (TopoI), topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs","volume":"156","author":"Baglini","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0540","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canlet.2017.04.041","article-title":"Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands","volume":"403","author":"Allison","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0545","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.canlet.2018.06.022","article-title":"Corrigendum to \u201cPreclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands\u201d [Canc. Lett. 403 (2017) 98\u2013107]","volume":"431","author":"Allison","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/ph13050091","article-title":"Is the way to fight cancer paved with gold? Metal-based carbene complexes with multiple and fascinating biological features","volume":"13","author":"Iacopetta","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0555","first-page":"76","article-title":"Gold-NHC complexes as potent bioactive compounds","volume":"1","author":"Al-Majid","year":"2016","journal-title":"Chem. Sel."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0560","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1002\/anie.201612583","article-title":"Cyclometalated gold(III) complexes containing N-heterocyclic Carbene ligands engage multiple anti-Cancer molecular targets","volume":"56","author":"Fung","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0565","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1039\/c001216e","article-title":"Cyclometalated gold(III) complexes with N-heterocyclic carbene ligands as topoisomerase i poisons","volume":"46","author":"Yan","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2015.02.001","article-title":"Macrophage and colon tumor cells as targets for a binuclear silver(I) N-heterocyclic carbene complex, an anti-inflammatory and apoptosis mediator","volume":"146","author":"Iqbal","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0575","series-title":"Met. Dev. Action Anticancer Agents","first-page":"507","article-title":"Targeting zinc(II) signalling to prevent cancer","author":"Ziliotto","year":"2018"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0580","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0079-6603(01)67026-0","article-title":"Cisplatin: from DNA damage to cancer chemotherapy","volume":"67","author":"Cohen","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0585","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.1039\/C7CC03074F","article-title":"On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging","volume":"53","author":"Karaca","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0590","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1039\/C8CS00157J","article-title":"Molecular methods for assessment of non-covalent metallodrug-DNA interactions","volume":"48","author":"Kellett","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0595","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ecoenv.2015.09.006","article-title":"Evidence of ATP assay as an appropriate alternative of MTT assay for cytotoxicity of secondary effluents from WWTPs","volume":"122","author":"Yang","year":"2015","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0600","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0022-2836(61)80004-1","article-title":"Structural considerations in the interaction of DNA and acridines","volume":"3","author":"Lerman","year":"1961","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0605","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ica.2015.08.017","article-title":"Novel silver(I)- and gold(I)-N-heterocyclic carbene complexes. Synthesis, characterization and evaluation of biological activity against tumor cells","volume":"437","author":"Sanchez","year":"2015","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0610","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.poly.2016.02.012","article-title":"Remarkable in vitro anti-HIV activity of new silver(I)- and gold(I)-N-heterocyclic carbene complexes. Synthesis, DNA binding and biological evaluation","volume":"110","author":"S\u00e1nchez","year":"2016","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0615","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.poly.2018.06.052","article-title":"Benzotriazole functionalized N-heterocyclic carbene\u2013silver(I) complexes: synthesis, cytotoxicity, antimicrobial, DNA binding, and molecular docking studies","volume":"153","author":"Onar","year":"2018","journal-title":"Polyhedron"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/aoc.3655","article-title":"Dose-, time-and lipophilicity-dependent silver(I)\u2013N-heterocyclic carbene complexes: synthesis, characterization and interaction with plasmid and Aedes albopictus DNA","volume":"31","author":"Asekunowo","year":"2017","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0625","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/aoc.2912","article-title":"Nitrile-functionalized Hg(II)- and Ag(I)-N-heterocyclic carbene complexes: synthesis, crystal structures, nuclease and DNA binding activities","volume":"26","author":"Haque","year":"2012","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0630","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejmech.2018.03.029","article-title":"Synthesis and characterization of nitrile functionalized silver(I)-N-heterocyclic carbene complexes: DNA binding, cleavage studies, antibacterial properties and mosquitocidal activity against the dengue vector, Aedes albopictus","volume":"150","author":"Asekunowo","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0635","doi-asserted-by":"crossref","first-page":"13523","DOI":"10.1039\/C8DT02507J","article-title":"Acridine-decorated cyclometallated gold(III) complexes: synthesis and anti-tumour investigations","volume":"47","author":"Williams","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0640","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cmdc.201402049","article-title":"Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators","volume":"9","author":"Meyer","year":"2014","journal-title":"ChemMedChem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0645","doi-asserted-by":"crossref","first-page":"110998","DOI":"10.1016\/j.jinorgbio.2020.110998","article-title":"Cytotoxic Ag(I) and au(I) NHC-carbenes bind DNA and show TrxR inhibition","volume":"205","author":"Guarra","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0650","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.3390\/molecules25225446","article-title":"On the different mode of action of au(I)\/Ag(I)-NHC Bis-Anthracenyl complexes towards selected target biomolecules","volume":"25","author":"Binacchi","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0655","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1039\/C5CS00132C","article-title":"Chemical biology of anticancer gold(III) and gold(i) complexes","volume":"44","author":"Zou","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0660","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1039\/c001216e","article-title":"Cyclometalated gold(III) complexes with N-heterocyclic carbene ligands as topoisomerase i poisons","volume":"46","author":"Yan","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0665","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/157018012803307987","article-title":"In vitro and in vivo investigations into the Carbene silver acetate anticancer drug candidate SBC1","volume":"9","author":"Fichtner","year":"2012","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0670","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41573-019-0042-3","article-title":"Targeting mRNA processing as an anticancer strategy","volume":"19","author":"Desterro","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0675","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ccr.2019.02.015","article-title":"Recent advances in metallodrug-like molecules targeting non-coding RNAs in cancer chemotherapy","volume":"387","author":"Arjmand","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0680","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1080\/00958972.2014.971405","article-title":"Counterion-induced modulation in biochemical properties of nitrile functionalized silver(I)-N-heterocyclic carbene complexes","volume":"67","author":"Asekunowo","year":"2014","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0685","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbpa.2017.10.029","article-title":"Metal complexes promoting catalytic cleavage of nucleic acids \u2014 biochemical tools and therapeutics","volume":"43","author":"Yu","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0690","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/acsmedchemlett.9b00289","article-title":"Targeting an artificial metal nuclease to DNA by a simple chemical modification and its drastic effect on catalysis","volume":"11","author":"Castilho","year":"2020","journal-title":"Acs Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0695","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1021\/cr00022a011","article-title":"Chemical nucleases","volume":"93","author":"Sigman","year":"1993","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0700","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/chem.200801992","article-title":"D\u00edez-Gonz\u00e1lez, L. Morel, A. Gautier, Toxicity of copper(I)-NHC complexes against human tumor cells: Induction of cell cycle arrest, apoptosis, and DNA cleavage","volume":"15","author":"Teyssot","year":"2009","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0705","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/aoc.3035","article-title":"Synthesis, structural and spectral properties of au complexes: luminescence properties and their non-covalent DNA binding studies","volume":"27","author":"Huerta-Aguilar","year":"2013","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0710","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1093\/nar\/gkl655","article-title":"Quadruplex DNA: sequence, topology and structure","volume":"34","author":"Burge","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0715","series-title":"Met. Dev. Action Anticancer Agents","first-page":"325","article-title":"Nucleic acid quadruplexes and metallo-drugs","author":"Vilar","year":"2018"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0720","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrm.2017.3","article-title":"DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential","volume":"18","author":"H\u00e4nsel-Hertsch","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0725","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/C6QI00300A","article-title":"G-quadruplex DNA targeted metal complexes acting as potential anticancer drugs","volume":"4","author":"Cao","year":"2017","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0730","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/molecules24030429","article-title":"Recent progress of targeted G-Quadruplex preferred ligands toward cancer therapy","volume":"24","author":"Asamitsu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0735","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1039\/C4CC00611A","article-title":"Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA","volume":"50","author":"Maji","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0740","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/C6QI00300A","article-title":"G-quadruplex DNA targeted metal complexes acting as potential anticancer drugs","volume":"4","author":"Cao","year":"2017","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0745","doi-asserted-by":"crossref","first-page":"0041","DOI":"10.1038\/s41570-017-0041","article-title":"Quadruplex nucleic acids as targets for anticancer therapeutics","volume":"1","author":"Neidle","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0750","doi-asserted-by":"crossref","first-page":"14432","DOI":"10.1038\/ncomms14432","article-title":"CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0755","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1158\/0008-5472.CAN-09-1304","article-title":"Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis","volume":"69","author":"Drygin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0760","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5483\/BMBRep.2013.46.1.123","article-title":"Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells","volume":"46","author":"Kim","year":"2013","journal-title":"Bmb Rep."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0765","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1021\/ic403011h","article-title":"Caffeine-based gold(I) N-heterocyclic carbenes as possible anticancer agents: synthesis and biological properties","volume":"53","author":"Bertrand","year":"2014","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0770","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cbic.201200396","article-title":"Assessing the differential affinity of small molecules for noncanonical DNA structures","volume":"13","author":"Stefan","year":"2012","journal-title":"ChemBioChem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0775","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/anie.201511999","article-title":"Determinants for tight and selective binding of a medicinal Dicarbene gold(I) complex to a Telomeric DNA G-Quadruplex: a joint ESI MS and XRD investigation","volume":"55","author":"Bazzicalupi","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0780","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1002\/chem.201702854","article-title":"[Au(9-methylcaffein-8-ylidene)2]+\/DNA Tel23 System: Solution, Computational, and Biological Studies","volume":"23","author":"Papi","year":"2017","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0785","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1002\/anie.201805727","article-title":"On the mechanism of gold\/NHC compounds binding to DNA G-Quadruplexes: combined Metadynamics and biophysical methods","volume":"57","author":"Wragg","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0790","doi-asserted-by":"crossref","first-page":"110844","DOI":"10.1016\/j.jinorgbio.2019.110844","article-title":"Comparative biological evaluation and G-quadruplex interaction studies of two new families of organometallic gold(I) complexes featuring N-heterocyclic carbene and alkynyl ligands","volume":"202","author":"Meier-Menches","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0795","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ejic.201901043","article-title":"Exploring the reactivity and biological effects of Heteroleptic N-heterocyclic Carbene gold(I)-Alkynyl complexes","volume":"2020","author":"Oberkofler","year":"2020","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0800","doi-asserted-by":"crossref","first-page":"16132","DOI":"10.1039\/C8DT03607A","article-title":"Interaction of a gold(I) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis","volume":"47","author":"Guarra","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0805","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1021\/acs.inorgchem.7b00339","article-title":"Cytotoxicity of pyrazine-based cyclometalated (C^Npz^C)Au(III) carbene complexes: impact of the nature of the ancillary ligand on the biological properties","volume":"56","author":"Bertrand","year":"2017","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0810","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1002\/chem.201705902","article-title":"A gold(III) pincer ligand scaffold for the synthesis of binuclear and bioconjugated complexes: synthesis and anticancer potential","volume":"24","author":"Bertrand","year":"2018","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0820","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2018.01.009","article-title":"The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions","volume":"360","author":"Bergamo","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0825","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1039\/c2sc20627g","article-title":"Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry?","volume":"3","author":"Casini","year":"2012","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0830","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.chemrev.8b00271","article-title":"Toward multi-targeted platinum and ruthenium drugs - a new paradigm in Cancer drug treatment regimens?","volume":"119","author":"Kenny","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0835","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101995","article-title":"NAMI-A and KP1019\/1339, two iconic ruthenium anticancer drug candidates face-to-face: a case story in medicinal inorganic chemistry","volume":"24","author":"Alessio","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2021.111355_bb0840","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acs.chemrev.8b00396","article-title":"Metal drugs and the anticancer immune response","volume":"119","author":"Englinger","year":"2019","journal-title":"Chem. Rev."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013421000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013421000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:02:58Z","timestamp":1758985378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013421000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":167,"alternative-id":["S0162013421000027"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111355","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111355"}}